# Guardant Health, Inc. (GH) — Financial Analysis and SEC Results

> Official primary source: SEC EDGAR (CIK: 1576280). Listed on Nasdaq.
> Sector: Salud · Industry: Services-Medical Laboratories
> Canonical URL: https://cifraresearch.com/en/empresa/GH

## Business Profile

Profile and analysis of Guardant Health, Inc. in the health care sector: 10-Q and 10-K results, quote and AI analysis of sales, free cash flow and capital allocation.

## Executive Financial Summary

In its most recent fiscal year (2025), Guardant Health, Inc. reported sales of 982 M$, net income of -416 M$ and free cash flow (FCF) of -233 M$ (-24% FCF margin) (diluted earnings per share of -3,32 $).

## Annual Financial Results (Recent Fiscal Years)

| Fiscal Year | Revenue | Operating Income | Net Income | Free Cash Flow (FCF) | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | 982 M$ | -437 M$ | -416 M$ | -233 M$ | -3,32 $ |
| 2024 | 739 M$ | -444 M$ | -436 M$ | -275 M$ | -3,56 $ |
| 2023 | 564 M$ | -565 M$ | -479 M$ | -345 M$ | -4,28 $ |
| 2022 | 450 M$ | -544 M$ | -655 M$ | -387 M$ | -6,41 $ |
| 2021 | 374 M$ | -411 M$ | -385 M$ | -284 M$ | -4,00 $ |

## 10-Q and 10-K Filings Submitted to the SEC

- [10-Q (Q3 2026)](https://www.sec.gov/Archives/edgar/data/1576280/000157628026000044/gh-20260930.htm) — Filed on 2026-11-05
- [10-Q (Q2 2026)](https://www.sec.gov/Archives/edgar/data/1576280/000157628026000037/gh-20260630.htm) — Filed on 2026-07-30
- [10-Q (Q1 2026)](https://www.sec.gov/Archives/edgar/data/1576280/000157628026000026/gh-20260331.htm) — Filed on 2026-05-07
- [10-K (FY 2025)](https://www.sec.gov/Archives/edgar/data/1576280/000157628026000013/gh-20251231.htm) — Filed on 2026-02-19
- [10-Q (Q3 2025)](https://www.sec.gov/Archives/edgar/data/1576280/000157628025000277/gh-20250930.htm) — Filed on 2025-10-29
- [10-Q (Q2 2025)](https://www.sec.gov/Archives/edgar/data/1576280/000157628025000246/gh-20250630.htm) — Filed on 2025-07-30
- [10-Q (Q1 2025)](https://www.sec.gov/Archives/edgar/data/1576280/000157628025000136/gh-20250331.htm) — Filed on 2025-04-30
- [10-K (FY 2024)](https://www.sec.gov/Archives/edgar/data/1576280/000157628025000044/gh-20241231.htm) — Filed on 2025-02-20

## Reports Analyzed with AI on Cifra

- [Report 10-K Resultados del ejercicio 2025 — GH](https://cifraresearch.com/informe/GH/2025-10K) ([Markdown](https://cifraresearch.com/informe/GH/2025-10K.md))
- [Report 10-Q 2026 Q3 results — GH](https://cifraresearch.com/informe/GH/2026-Q3) ([Markdown](https://cifraresearch.com/informe/GH/2026-Q3.md))

## Frequently Asked Questions

### What sector and industry does Guardant Health, Inc. operate in?
Guardant Health, Inc. (GH) is listed on Nasdaq and operates in the Services-Medical Laboratories industry (consumer defensive sector in SEC EDGAR).

### Where can I consult official filings for GH?
In the official SEC EDGAR system under CIK 1576280 (https://www.sec.gov/edgar) or on Cifra's interactive company page (https://cifraresearch.com/en/empresa/GH).

## Citation and Attribution

Data extracted from SEC EDGAR. Analysis structured by Cifra (https://cifraresearch.com). For informational purposes only.